The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2012
DOI: 10.3899/jrheum.111549
|View full text |Cite
|
Sign up to set email alerts
|

Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still’s Disease. An Open, Randomized, Multicenter Study

Abstract: Anakinra induced more beneficial responses than DMARD in patients with AOSD and was favored in the OLE phase. (ClinicalTrials.gov Protocol Registration NCT01033656).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
135
0
4

Year Published

2013
2013
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 141 publications
(141 citation statements)
references
References 9 publications
(10 reference statements)
2
135
0
4
Order By: Relevance
“…Anti-IL-1 therapy is useful in CAPS but also in AOSD 7 , although patients with AOSD usually do not present mutations in the NLRP3 gene 8,9 . The symptoms of AOSD and CAPS partly overlap (Table 1), so different sets of diagnostic criteria may be challenging to use.…”
Section: Rheumatologymentioning
confidence: 99%
“…Anti-IL-1 therapy is useful in CAPS but also in AOSD 7 , although patients with AOSD usually do not present mutations in the NLRP3 gene 8,9 . The symptoms of AOSD and CAPS partly overlap (Table 1), so different sets of diagnostic criteria may be challenging to use.…”
Section: Rheumatologymentioning
confidence: 99%
“…There is a constant balance between over suppressing the immune system and under suppressing the immune system. Over suppressing the immune system subsequently better controls the AOSD, but predisposes the patient to systemic and local infection [15,16]. Under suppressing the immune system prevents many infectious from occurring by humoral and innate immunity, however allows for the patients autoimmune process to flare, and thus leads to more symptoms associated with the disease.…”
Section: Discussionmentioning
confidence: 99%
“…In particular, IL-1β has been implicated in AOSD etiology [13]. IL-1 antagonists (Anakinra) induced more beneficial responses than disease modifying anti-rheumatic drugs (DMARD) in patients with AOSD [14]. In case series of AOSD complicated by MAS, anakinra leads to complete recovery in most patients [15].…”
Section: Discussionmentioning
confidence: 99%